Navigation Links
Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
Date:8/19/2007

HO ELECTED CONVERSION.

About PharmAthene, Inc.

PharmAthene is a biodefense company formed in 2001 to meet the critical needs of the United States by developing biodefense products. PharmAthene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror. PharmAthene's lead programs include Valortim(TM) and Protexia(R). For more information on PharmAthene, please visit its website at http://www.PharmAthene.com.


'/>"/>
SOURCE PharmAthene, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Green County courts to hold hearings via video conferencing
2. Public Hearing Held for controversial anti-cloning bills
3. Delaware company will keep NameProtect here
4. Wisconsin Supreme Court to hear Menasha software case
5. Supreme Court limits foreign reach of U.S. patents
6. High court sends message on patent obviousness
7. Supreme Court ruling seen as blow to WARF stem cell patents
8. Software tax dispute could go the Supreme Court
9. Wisconsin court halts Abbotts sale of genotyping products
10. Wisconsin court affirms damages in Innogenetics, Abbott patent case
11. With patents, Wisconsin court gaining reputation as a "rocket docket"
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 2Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4Study confirms association between tobacco smoke and behavioral problems in children 2Reportlinker Adds World Cardiac Biomarkers Market Report 56775 1Reportlinker Adds World Cardiac Biomarkers Market Report 56775 2Reportlinker Adds World Cardiac Biomarkers Market Report 56775 3Reportlinker Adds World Cardiac Biomarkers Market Report 56775 4Reportlinker Adds World Cardiac Biomarkers Market Report 56775 5Reportlinker Adds World Cardiac Biomarkers Market Report 56775 6Reportlinker Adds World Cardiac Biomarkers Market Report 56775 7Reportlinker Adds World Cardiac Biomarkers Market Report 56775 8Reportlinker Adds World Cardiac Biomarkers Market Report 56775 9Reportlinker Adds World Cardiac Biomarkers Market Report 56775 10Reportlinker Adds World Cardiac Biomarkers Market Report 56775 11Reportlinker Adds World Cardiac Biomarkers Market Report 56775 12Reportlinker Adds World Cardiac Biomarkers Market Report 56775 13Reportlinker Adds World Cardiac Biomarkers Market Report 56775 14Reportlinker Adds World Cardiac Biomarkers Market Report 56775 15Reportlinker Adds World Cardiac Biomarkers Market Report 56775 16Reportlinker Adds World Cardiac Biomarkers Market Report 56775 17Reportlinker Adds World Cardiac Biomarkers Market Report 56775 18Americans Urged To Get Seasonal Influenza Vaccine Early 56771 1Americans Urged To Get Seasonal Influenza Vaccine Early 56771 2Americans Urged To Get Seasonal Influenza Vaccine Early 56771 3Americans Urged To Get Seasonal Influenza Vaccine Early 56771 4Americans Urged To Get Seasonal Influenza Vaccine Early 56771 5Americans Urged To Get Seasonal Influenza Vaccine Early 56771 6University of Arizona researchers seek safer cystic fibrosis test 56767 1University of Arizona researchers seek safer cystic fibrosis test 56767 2